Who should be prioritised for COVID-19 vaccination?

被引:53
|
作者
Russell, Fiona M. [1 ,2 ]
Greenwood, Brian [3 ]
机构
[1] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[2] Murdoch Childrens Res Inst, Asia Pacific Hlth Res, Melbourne, Vic, Australia
[3] London Sch Hyg & Trop Med, Dept Dis Control, London, England
基金
英国医学研究理事会;
关键词
COVID-19; vaccines; high-risk; epidemiology; transmission; vaccine development; clinical trials; WOMEN;
D O I
10.1080/21645515.2020.1827882
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine to be available within 6 months. So who should be prioritized for vaccination when in the first instance, there will be insufficient supply to meet demand? There is no doubt that health-care workers in all settings should be vaccinated first, but who comes next will be a complex decision based on local epidemiology, societal values, and the ability of the vaccines to prevent both severe disease and to reduce transmission thereby eliciting herd protection. The decision on who to vaccinate should be equitable, highly contextualized, and based on the property of each vaccine. In some settings, the elderly may be prioritized, in others, it may be the population most likely to get infected and responsible for community spread. To support decision-making on who to be prioritized for vaccination requires urgent additional research on the epidemiology of COVID-19; preexisting immunity and who is responsible for transmission in a variety of settings; the safety, immunogenicity, and efficacy of COVID-19 vaccines in children and pregnant women; and determining whether COVID-19 vaccines prevent asymptomatic infection and transmission.
引用
收藏
页码:1317 / 1321
页数:5
相关论文
共 50 条
  • [41] The impact of COVID-19 and COVID vaccination on cardiovascular outcomes
    Akhtar, Zubair
    Trent, Mallory
    Moa, Aye
    Tan, Timothy C.
    Froebert, Ole
    MacIntyre, C. Raina
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : A42 - A49
  • [42] Uptake of COVID-19 vaccination among people who inject drugs
    Jenny Iversen
    Handan Wand
    Robert Kemp
    Jude Bevan
    Myf Briggs
    Kate Patten
    Sue Heard
    Lisa Maher
    Harm Reduction Journal, 19
  • [43] COVID-19 vaccine willingness prior to and during the COVID-19 vaccination rollout in Australia
    Wang, Bing
    Nolan, Rebecca
    Krumeich, Benjamin
    D'Onise, Katina
    Marshall, Helen
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [44] Uptake of COVID-19 vaccination among people who inject drugs
    Iversen, Jenny
    Wand, Handan
    Kemp, Robert
    Bevan, Jude
    Briggs, Myf
    Patten, Kate
    Heard, Sue
    Maher, Lisa
    HARM REDUCTION JOURNAL, 2022, 19 (01)
  • [45] Who should perform the rhinopharyngeal swab in COVID-19 positive patients?
    De Virgilio, Armando
    Pellini, Raul
    Mercante, Giuseppe
    Ferreli, Fabio
    Petruzzi, Gerardo
    Spriano, Giuseppe
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (06): : 1250 - 1251
  • [46] Anesthesia and COVID-19: What We Should Know and What We Should Do
    Tang, Linda Y.
    Wang, Jingping
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 24 (02) : 127 - 137
  • [47] Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination
    Iba, Toshiaki
    Levy, Jerrold H.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2022, 32 (05) : 249 - 256
  • [48] Subacute Thyroiditis Following COVID-19 and COVID-19 Vaccination
    Duskin-Bitan, Hadar
    Robenshtok, Eyal
    Peretz, Alon
    Beckenstein, Tanya
    Tsur, Nir
    Netzer, Doron
    Cohen, Arnon D.
    Saliba, Walid
    Shimon, Ilan
    Gorshtein, Alexander
    ENDOCRINE PRACTICE, 2024, 30 (08) : 731 - 736
  • [49] Skin manifestations of COVID-19 and after COVID-19 vaccination
    Reinhart, Manuel
    Metze, Dieter
    Braun, Stephan A.
    HAUTARZT, 2022, 73 (06): : 434 - 441
  • [50] Neurological Disorders following COVID-19 Vaccination
    Yang, Ying
    Huang, Lisu
    VACCINES, 2023, 11 (06)